AF, S., K, K., WS, M., PH, D., JK, D., KJ, D., . . . RS, O. (2011). Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors. Journal of medicinal chemistry, 54(22), 7772. https://doi.org/10.1021/jm200893p
Chicago Style (17th ed.) CitationAF, Stepan, et al. "Metabolism-directed Design of Oxetane-containing Arylsulfonamide Derivatives as γ-secretase Inhibitors." Journal of Medicinal Chemistry 54, no. 22 (2011): 7772. https://doi.org/10.1021/jm200893p.
MLA (9th ed.) CitationAF, Stepan, et al. "Metabolism-directed Design of Oxetane-containing Arylsulfonamide Derivatives as γ-secretase Inhibitors." Journal of Medicinal Chemistry, vol. 54, no. 22, 2011, p. 7772, https://doi.org/10.1021/jm200893p.
Warning: These citations may not always be 100% accurate.